News
MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS) ...
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) said it scaled up its production of PrimeC to a commercial scale. PrimeC, ...
The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros ...
First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...
If you’ve been on Instagram recently, you may have seen Insta stories of giddy teens dumping water — which doesn’t even ...
9hon MSN
Billy Evans, partner of incarcerated Theranos founder Elizabeth Holmes, has reportedly raised millions for a startup called ...
11h
GlobalData on MSNLilly-Purdue partnership to invest $250m in pharma innovationEli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...
Leading clinician Professor Chris McDermott has been named a recipient of The ALS Association's 2025 Sheila Essey Award for ...
4hon MSN
This year’s guest hosts are former college quarterbacks Jeff Burger and Jake Coker. It will mark the first time representatives from both Auburn and Alabama will work together as guest hosts to ...
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results